Enovis ENOV Reconstructive — Operating Costs and Expenses

Other segment segments

Similar metrics at other companies

IAR

IARTTissue Reconstruction — Total Costs & Expenses

$88.52M-9.3%

DLXRestructuring operating expense

$3.4M-55.8%

ITG

ITGRRestructuring and other charges

$4.47M+47.1%

BILLRestructuring

$5.04M—

IAR

IARTTissue Reconstruction — Operating Income (Loss)

$20.27M+356%

IAR

IARTTissue Reconstruction — Cost of goods sold

$37.46M-24.0%

Questions, answered.

What is Enovis's reconstructive — operating costs and expenses?

Enovis (ENOV) reported reconstructive — operating costs and expenses of $270.4M in Q1 2026.

How has Enovis's reconstructive — operating costs and expenses changed year-over-year?

Enovis's reconstructive — operating costs and expenses increased by 6.1% year-over-year, from $254.97M to $270.4M.

What is the long-term trend for Enovis's reconstructive — operating costs and expenses?

Over 3 years (2022 to 2025), Enovis's reconstructive — operating costs and expenses has grown at a 25.8% compound annual growth rate (CAGR), from $493.04M to $982.18M.

What does reconstructive — operating costs and expenses mean?

The aggregate of all costs incurred to operate the reconstructive segment, including production, R&D, and administrative expenses. This metric is used to evaluate the overall cost management and operational efficiency of the business unit.